MicroRNA-143/-145 in cardiovascular diseases

102Citations
Citations of this article
112Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

MicroRNAs (miRNAs) play an essential role in the onset and development of many cardiovascular diseases. Increasing evidence shows that miRNAs can be used as potential diagnostic biomarkers for cardiovascular diseases, and miRNA-based therapy may be a promising therapy for the treatment of cardiovascular diseases. The microRNA-143/-145 (miR-143/-145) cluster is essential for differentiation of vascular smooth muscle cells (VSMCs) and determines VSMC phenotypic switching. In this review, we summarize the recent progress in knowledge concerning the function of miR-143/-145 in the cardiovascular system and their role in cardiovascular diseases. We discuss the potential role of miR-143/-145 as valuable biomarkers for cardiovascular diseases and explore the potential strategy of targeting miR-143 and miR-145.

Cite

CITATION STYLE

APA

Zhao, W., Zhao, S. P., & Zhao, Y. H. (2015). MicroRNA-143/-145 in cardiovascular diseases. BioMed Research International. Hindawi Limited. https://doi.org/10.1155/2015/531740

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free